English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Noncanonical Regulation of HOIL-1 on Cancer Stemness and Sorafenib Resistance Identifies Pixantrone as A Novel Therapeutic Agent for Hepatocellular Carcinoma Journal article
Chen, Peng, Dong, Zheyu, Zhu, Wei, Chen, Junling, Zhou, Yuxin, Ye, Qiuyue, Liao, Xinxin, Tan, Yongfa, Li, Chuanjiang, Wang, Yuhao, Pang, Huajin, Wen, Chunhua, Jiang, Yuchuan, Li, Xiaoqing, Li, Bo, Aimaier, Aihetaimu, Lin, Li, Sun, Jian, Hou, Jiajie, Tang, Libo, Hou, Jinlin, Li, Yongyin. Noncanonical Regulation of HOIL-1 on Cancer Stemness and Sorafenib Resistance Identifies Pixantrone as A Novel Therapeutic Agent for Hepatocellular Carcinoma[J]. Hepatology, 2024.
Authors:  Chen, Peng;  Dong, Zheyu;  Zhu, Wei;  Chen, Junling;  Zhou, Yuxin; et al.
Favorite |   IF:12.9/15.5 | Submit date：2023/08/31
Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for HCC Journal article
Chen, Peng, Dong, Zheyu, Zhu, Wei, Chen, Junling, Zhou, Yuxin, Ye, Qiuyue, Liao, Xinxin, Tan, Yongfa, Li, Chuanjiang, Wang, Yuhao, Pang, Huajin, Wen, Chunhua, Jiang, Yuchuan, Li, Xiaoqing, Li, Bo, Aimaier, Aihetaimu, Lin, Li, Sun, Jian, Hou, Jiajie, Tang, Libo, Hou, Jinlin, Li, Yongyin. Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for HCC[J]. Hepatology, 2024, 80(2), 330-345.
Authors:  Chen, Peng;  Dong, Zheyu;  Zhu, Wei;  Chen, Junling;  Zhou, Yuxin; et al.
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:12.9/15.5 | Submit date：2024/08/05
Hepatocellular-carcinoma  Up-regulation  Inhibition  Activation  Growth  Cells